Literature DB >> 18632033

Diagnosis of diabetic peripheral neuropathy among patients with type 1 and type 2 diabetes in France, Italy, Spain, and the United Kingdom.

Annalisa Rubino1, Matthew D Rousculp, Kimberly Davis, Jianmin Wang, Edward J Bastyr, Solomon Tesfaye.   

Abstract

AIMS: The objective of this study was to describe the proportion and characteristics of patients with type 1 and type 2 diabetes diagnosed with diabetic peripheral neuropathy (DPN) in France, Italy, Spain, and the United Kingdom (UK).
METHODS: A cross-sectional survey was administered to general practitioners and diabetes specialists. Existing physicians' records were used to quantify the frequency of DPN diagnoses, and notes from patients' medical charts were used to characterize symptoms.
RESULTS: The average number of physicians per country was 41 (range of 34-49). The proportion of diabetes patients diagnosed with DPN ranged from 9.6% (95% CI, 7.1-12.2) in Spain to 23.1% (95% CI, 15.4-30.7) in Italy. Of 913 DPN study patients, 55.0% were male, and 78.5% had type 2 diabetes. Mean age was 64.5+/-12.5 years. A DPN diagnosis was based primarily on symptoms. Approximately 27% of patients had no documented neurological examination. "Prickling" was the most common DPN symptom recorded in France, Italy, and Spain, and "numbness" was the most common in the UK.
CONCLUSIONS: Country-specific estimates of DPN diagnosis may reflect clinical management of diabetes and DPN. A substantial number of diagnoses were not associated with a record of a neurological examination.

Entities:  

Mesh:

Year:  2007        PMID: 18632033     DOI: 10.1016/j.pcd.2007.07.006

Source DB:  PubMed          Journal:  Prim Care Diabetes        ISSN: 1878-0210            Impact factor:   2.459


  8 in total

1.  Treatment-induced neuropathy of diabetes: an acute, iatrogenic complication of diabetes.

Authors:  Christopher H Gibbons; Roy Freeman
Journal:  Brain       Date:  2014-11-11       Impact factor: 13.501

2.  Chinese herbal medicine for diabetic peripheral neuropathy: an updated meta-analysis of 10 high-quality randomized controlled studies.

Authors:  Chi-zi Hao; Fan Wu; Lin Lu; Juan Wang; Yi Guo; Ai-ju Liu; Wei-jing Liao; Guo-qing Zheng
Journal:  PLoS One       Date:  2013-10-16       Impact factor: 3.240

Review 3.  Botulinum Toxin Type A for the Treatment of Neuropathic Pain in Neuro-Rehabilitation.

Authors:  Domenico Intiso; Mario Basciani; Andrea Santamato; Marta Intiso; Filomena Di Rienzo
Journal:  Toxins (Basel)       Date:  2015-06-30       Impact factor: 4.546

4.  Prevalence and risk factors of development of peripheral diabetic neuropathy in type 2 diabetes mellitus in a tertiary care setting.

Authors:  Dipika Bansal; Kapil Gudala; Harini Muthyala; Hari Prasad Esam; Ramya Nayakallu; Anil Bhansali
Journal:  J Diabetes Investig       Date:  2014-04-02       Impact factor: 4.232

5.  Evaluation of the healthy median nerve elasticity: Feasibility and reliability of shear wave elastography.

Authors:  Bihui Zhu; Feng Yan; Ying He; Liyun Wang; Xi Xiang; Yuanjiao Tang; Yujia Yang; Li Qiu
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

6.  Examining practice effects in repeated measurements of vibration perception thresholds on finger pulps of healthy individuals - Is it possible to improve your results over a clinically relevant test interval?

Authors:  Linnéa Ekman; Jin Persson Löfgren; Lars B Dahlin
Journal:  PLoS One       Date:  2019-12-17       Impact factor: 3.240

7.  Diabetic Peripheral Neuropathy Associated with Cardiovascular Risk Factors and Glucagon-Like Peptide-1 Concentrations Among Newly Diagnosed Patients with Type 2 Diabetes Mellitus.

Authors:  Tuan Dinh Le; Thuc Luong Cong; Duc-Cuong Le; Nga Phi Thi Nguyen; Hoa Thanh Thi Tran; Lan Ho Thi Nguyen; Binh Do Nhu; Son Tien Nguyen; Manh Van Ngo; Hoa Trung Dinh; Hien Thi Nguyen; Kien Trung Nguyen
Journal:  Diabetes Metab Syndr Obes       Date:  2022-01-06       Impact factor: 3.168

8.  Prevalence of and Risk Factors for Peripheral Neuropathy in Chinese Patients With Diabetes: A Multicenter Cross-Sectional Study.

Authors:  Qi Pan; Quanmin Li; Wei Deng; Dong Zhao; Lin Qi; Wei Huang; Li Ma; Hongmei Li; Yufeng Li; Xiaofeng Lyu; Aihong Wang; Hebin Yao; Xiaoyan Xing; Lixin Guo
Journal:  Front Endocrinol (Lausanne)       Date:  2018-11-05       Impact factor: 5.555

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.